The penicillins and streptomycins dosage market in Moldova has demonstrated variability over the past decade, with a notable decline from 2013 to 2023. The market peaked in 2013 and experienced a general downward trend, reaching its lowest point in 2023 at a value of 5.7766 million USD. Over the past five years, the market experienced an average annual decrease (CAGR) of -6.74%, indicating a consistent contraction. Short-term fluctuations revealed a general volatility with both declines and minor recoveries, such as a market uptick in 2021.
Future market trends to watch for include potential recovery influenced by increased awareness of antimicrobial resistance, possibly spurring higher demand for alternative treatments or advanced formulations. Other factors to consider are changes in healthcare policies, international trade agreements, or economic shifts that could impact both supply chains and pricing dynamics, potentially stabilizing or further weakening the market.
How does Moldova rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 28 | 28 Nicaragua | 15,976,000 | 2023 | -0.12% | +0.75% | View data |
| 29 | 29 Kyrgyzstan | 10,516,000 | 2023 | -0.4% | -0.84% | View data |
| 30 | 30 Moldova | 5,776,600 | 2023 | -4.38% | -6.74% | |
| 31 | 31 Armenia | 5,084,600 | 2023 | -2.21% | -0.94% | View data |
| 32 | 32 Luxembourg | 3,435,800 | 2023 | +0.84% | +2.7% | View data |
